Related content

Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays

By Ono Shigeshi   Lam Stella   Nagahara Makoto   Hoon Dave S. B.  

Journal of Clinical Medicine, Vol. 4, Iss. 10, 2015-10 ,pp. : 1890-1907

MDPI

Access to resources Recommend Favorite

MicroRNA Signatures as Biomarkers and Therapeutic Target for CNS Embryonal Tumors: The Pros and the Cons

By Shalaby Tarek   Fiaschetti Giulio   Baumgartner Martin   Grotzer Michael A.  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 21554-21586

MDPI

Access to resources Recommend Favorite

Correction: Grömminger, S., et al. Fetal Aneuploidy Detection by Cell-Free DNA Sequencing for Multiple Pregnancies and Quality Issues with Vanishing Twins. J. Clin. Med. 2014, 3, 679-692

By Grömminger Sebastian   Yagmur Erbil   Erkan Sanli   Nagy Sándor   Schöck Ulrike   Bonnet Joachim   Smerdka Patricia   Ehrich Mathias   Wegner Rolf-Dieter   Hofmann Wera   Stumm Markus  

Journal of Clinical Medicine, Vol. 3, Iss. 4, 2014-11 ,pp. : 1333-1334

MDPI

Access to resources Recommend Favorite

MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer

By An Fangmei   Olaru Alexandru V.   Mezey Esteban   Xie Qing   Li Ling   Piontek Klaus B.   Selaru Florin M.  

Journal of Clinical Medicine, Vol. 4, Iss. 9, 2015-08 ,pp. : 1713-1728

MDPI

Access to resources Recommend Favorite

Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer

By Schou Jakob Vasehus   Johansen Julia Sidenius   Nielsen Dorte   Rossi Simona  

Non-Coding RNA, Vol. 2, Iss. 2, 2016-06 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite